全文获取类型
收费全文 | 2587582篇 |
免费 | 184733篇 |
国内免费 | 7573篇 |
专业分类
耳鼻咽喉 | 34272篇 |
儿科学 | 85196篇 |
妇产科学 | 71568篇 |
基础医学 | 363566篇 |
口腔科学 | 69658篇 |
临床医学 | 234494篇 |
内科学 | 515492篇 |
皮肤病学 | 62450篇 |
神经病学 | 213440篇 |
特种医学 | 99876篇 |
外国民族医学 | 736篇 |
外科学 | 386403篇 |
综合类 | 50391篇 |
现状与发展 | 5篇 |
一般理论 | 968篇 |
预防医学 | 196165篇 |
眼科学 | 56663篇 |
药学 | 187985篇 |
8篇 | |
中国医学 | 5331篇 |
肿瘤学 | 145221篇 |
出版年
2021年 | 19980篇 |
2019年 | 20619篇 |
2018年 | 29283篇 |
2017年 | 22591篇 |
2016年 | 26223篇 |
2015年 | 29499篇 |
2014年 | 40437篇 |
2013年 | 60418篇 |
2012年 | 80218篇 |
2011年 | 84478篇 |
2010年 | 51002篇 |
2009年 | 49141篇 |
2008年 | 79018篇 |
2007年 | 83833篇 |
2006年 | 85563篇 |
2005年 | 81724篇 |
2004年 | 78718篇 |
2003年 | 76036篇 |
2002年 | 73328篇 |
2001年 | 128406篇 |
2000年 | 131329篇 |
1999年 | 110497篇 |
1998年 | 31252篇 |
1997年 | 27919篇 |
1996年 | 28217篇 |
1995年 | 27383篇 |
1994年 | 25067篇 |
1993年 | 23419篇 |
1992年 | 85159篇 |
1991年 | 81563篇 |
1990年 | 78783篇 |
1989年 | 76059篇 |
1988年 | 69468篇 |
1987年 | 67996篇 |
1986年 | 63542篇 |
1985年 | 60510篇 |
1984年 | 44940篇 |
1983年 | 37943篇 |
1982年 | 22456篇 |
1981年 | 19984篇 |
1979年 | 38959篇 |
1978年 | 27439篇 |
1977年 | 23252篇 |
1976年 | 21495篇 |
1975年 | 22813篇 |
1974年 | 26786篇 |
1973年 | 25370篇 |
1972年 | 23749篇 |
1971年 | 21955篇 |
1970年 | 20183篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
Wojciech Szychta M.D. Ph.D. Gheorghe Cerin M.D. Ph.D. F.E.S.C. Bogdan Adrian Popa M.D. Armienti Felice M.D. Guido Lanzillo M.D. Ph.D. Marco Diena M.D. Grzegorz Opolski M.D. Ph.D. F.E.S.C. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(6):1040-1043
Sinus venosus atrial septal defect (SV‐ASD) usually coexists with partial anomalous pulmonary vein connection (PAPVC). It is a difficult diagnosis in transthoracic echocardiography (TTE) due to eccentric position of defects. We present a rare case of atypical anatomical variation in PAPVC, which was never described before. Two right pulmonary veins drained into superior vena cava, which overrode SV‐ASD and interatrial septum, a third pulmonary vein into the right atrium. Complete diagnosis could not be set after TTE, nor transesophageal echocardiography, whereas angio‐CT was finally conclusive. This diagnostic approach allowed the surgical planning. 相似文献
7.
8.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
9.
Zhenzhen Zhang Mark Garzotto Tomasz M. Beer Philippe Thuillier Stephen Lieberman Motomi Mori 《Nutrition and cancer》2016,68(8):1309-1319
Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P = 0.69) or Ki-67 (P = 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (all P > 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue. 相似文献
10.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients 下载免费PDF全文